Eli Lilly Stock News

Analysts expect that Eli Lilly and Company (NYSE:LLY) will announce $7.56 billion in sales for the current fiscal quarter, according to Zacks. Two analysts have made estimates for Eli Lilly ands earnings, with estimates ranging from $7.15 billion to $7.97 billion. Eli Lilly and reported sales of $7.44 billion in the same quarter last year, []

Related Stocks: ANTM , TGT , CL , MCK , GS , BIIB , MRNA , KSS , SBUX , ZBRA , IPG , MMM , PG , LLY , HON , ADSK , MRK , HLT , MO , BBY , ODFL , HUM , HPQ , LOW ,

Eli Lilly and Company (NYSE:LLY) major shareholder Lilly Endowment Inc sold 205,000 shares of the firms stock in a transaction that occurred on Wednesday, December 15th. The stock was sold at an average price of $271.90, for a total transaction of $55,739,500.00. The transaction was disclosed in a document filed with the SEC, which can []

Atlas Capital Advisors LLC grew its position in Eli Lilly and Company (NYSE:LLY) by 5,448.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 5,937 shares of the company’s stock after acquiring an additional 5,830 shares during the quarter. Atlas […]

Signaturefd LLC grew its position in Eli Lilly and Company (NYSE:LLY) by 10.5% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 18,477 shares of the companys stock after acquiring an additional 1,761 shares during the quarter. Signaturefd LLCs holdings in Eli Lilly and []

Equities research analysts at Mizuho began coverage on shares of Eli Lilly and (NYSE:LLY) in a research note issued to investors on Thursday, TipRanks reports. The firm set a buy rating and a $272.00 price target on the stock. Mizuhos price objective points to a potential downside of 3.24% from the stocks current price. Several []

Community Bank N.A. lowered its holdings in shares of Eli Lilly and Company (NYSE:LLY) by 16.0% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,245 shares of the companys stock after selling 807 shares during the period. Community Bank N.A.s []

Eli Lilly and Company (NYSE: LLY ) traded at a new 12-month high today of $283.90. So far today approximately 2.7 million shares have been exchanged, as compared to an average 30-day volume of 3.3 million shares. Eli Lilly and Company has overhead space with shares priced $278.50, or 2.5% below the average consensus analyst price target of $285.60. In the past 12 months, shares of Eli Lilly and Company have traded between a low of $158.05 and a high of $283.90 and are now at $278.50, which is 76% above that low price. Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, oncology, and immunology. Lillys key products include Full story available on Benzinga.com

DUBLIN--(BUSINESS WIRE)--The "Injection Pen Market by Product Type (Disposable, Reusable Pens), Therapy (Diabetes (Insulin, GLP-1), Growth Hormone, Osteoporosis, Fertility, Autoimmune disease, Cancer), End User (Hospitals, Clinics, Home Care), and Region - Global Forecast to 2026" report has been added to ResearchAndMarkets.com''s offering. The global injection pens market is projected to reach USD 53.3 billion by 2026 from USD 37.6 billion in 2021, at a CAGR of 7.2%. Growing prevalence of chron

Tower Bridge Advisors lifted its position in Eli Lilly and Company (NYSE:LLY) by 11.1% in the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 8,192 shares of the companys stock after acquiring an additional 816 shares during the period. Tower Bridge Advisors holdings in Eli Lilly and []

Related Stocks: VFC , LLY ,

Hills Bank & Trust Co raised its position in Eli Lilly and Company (NYSE:LLY) by 8.6% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 7,591 shares of the companys stock after buying an additional 598 shares during the period. Hills Bank []

Avitas Wealth Management LLC acquired a new stake in shares of Eli Lilly and Company (NYSE:LLY) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 20,557 shares of the companys stock, valued at approximately $4,750,000. Several other hedge funds and other institutional []